Advertisement

Himalayan General Insurance Co. Ltd (HGI)

Non-Life Insurance · Rs. 520.00 -20.10 (-3.72%) as of May 5, 2022

Price — last 6 months

Full chart →
Open
549.00
High / Low
549.00 / 520.00
Prev. close
540.10
Volume
3,117
52-week high
920.77
52-week low
520.00
Market cap
Shares outstanding

MASTER score

Mechanical 0–100 technical ranking. Methodology →

Promoter holding
Public holding

Stock performance

1-week change
-9.72%
1-month change
-14.75%
3-month change
-28.43%
6-month change
-27.87%
YTD change
-13.35%
1-year change
-20.44%
1-month high
631.30
1-month low
520.00
From 52-week high
-43.53%
From 52-week low
0.00%
180-day avg price
641.22
360-day avg price
678.79
Avg volume (1w)
2,321
Avg volume (1m)
4,964
Avg volume (6m)
14,252
Avg volume (12m)
30,096
Daily volatility (1m)
2.23%
Beta vs NEPSE (1y)

Valuation

EPS (annualized)
EPS (TTM)
P/E
P/B
Book value / share
ROE
ROA
Net profit margin
Graham number
Dividend yield
Dividend

P/E and P/B use the latest close over per-share values from the company's most recent filed statement. Full dividend history →

Key indicators vs Non-Life Insurance

EPS (Rs.)
N/A
min avg max
P/E
N/A
min avg max
P/B
N/A
min avg max
Networth / Share (Rs.)
N/A
min avg max
ROE (%)
N/A
min avg max

Technical indicators

RSI (14)29.42Oversold
MACD-24.32Bearish
EMA 5546.18Bearish
EMA 20579.57Bearish
EMA 180643.33Bearish
SMA 50624.03Bearish
SMA 200669.85Bearish
Pivot levels (classic)
S3
481.33
S2
500.67
S1
510.33
PP
529.67
R1
539.33
R2
558.67
R3
568.33

Key financials — last 8 quarters

amounts in Rs · per-share in Rs

No filed statements found.

More Non-Life Insurance stocks

HGI — frequently asked questions

What is Himalayan General Insurance Co. Ltd's share price?

Rs. 520.00 as of May 5, 2022, the latest NEPSE trading session (-3.72% on the day).

What is HGI's 52-week range?

Rs. 520.00 to Rs. 920.77.

What dividend did HGI pay?

No dividend on record for the most recent fiscal year in our data.

Prices from the latest NEPSE session; fundamentals from the company's published quarterly statements. Research reference only — not investment advice.